Citadel L5 HB

Company: Boehringer Ingelheim Animal Health

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

Citadel L5 HB Indications

This product has been shown to be effective for the vaccination of healthy cattle or swine against Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

This product has also been shown to be effective against urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated heifers subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

Directions and dosage: Mix well before use. Using aseptic technique, inject 2 mL subcutaneously or intramuscularly in healthy cattle, or intramuscularly in swine. A second dose is recommended 3 to 6 weeks later. Contact your veterinarian or the manufacturer for information on revaccination frequency.

Precautions

Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant animals. In case of human exposure, contact a physician.

Preservatives: Neomycin and thimerosal.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/2665.00

CPN: 1028285.1